FDA clears Accuray's radiosurgery platform
The FDA has granted Accuray 510(k) clearance to market Lung Optimized Treatment, a component of the CyberKnife VSI system.

The Lung Optimized Treatment allows treatment of lung tumors without the need to implant fiducial markers, according to Sunnyvale, Calif.-based Accuray. Simulation and comparison workflows, combined with tracking modes, allow the clinician to select from multiple, non-invasive treatment options.